Evidence map›Paper›PMID 31403624›Full record

ArticleJournal of visualized experiments : JoVE2019

Optimization, Design and Avoiding Pitfalls in Manual Multiplex Fluorescent Immunohistochemistry.

Jenny Lazarus, Yagiz Akiska, Mirna Perusina Lanfranca, Lawrence Delrosario, Lei Sun, Daniel Long, Jiaqi Shi, Howard Crawford, Marina P Di Magliano, Weiping Zou and 1 more

Open access · greenAbstract readVideo-Audio Media
In one paragraph

Article in Journal of visualized experiments : JoVE, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Topological importance of CD8Annals of hematology · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Jenny LazarusDepartment of Surgery, University of Michigan.
Yagiz AkiskaDepartment of Surgery, University of Michigan.
Mirna Perusina LanfrancaDepartment of Surgery, University of Michigan.
Lawrence DelrosarioDepartment of Surgery, University of Michigan.
Lei SunDepartment of Surgery, University of Michigan.
Daniel LongDepartment of Molecular and Cellular Physiology, University of Michigan.
Jiaqi ShiDepartment of Pathology, University of Michigan.
Howard CrawfordDepartment of Molecular and Cellular Physiology, University of Michigan.
Marina P Di MaglianoDepartment of Surgery, University of Michigan.
Weiping ZouDepartment of Surgery, University of Michigan.
Timothy FrankelDepartment of Surgery, University of Michigan; timofran@med.umich.edu.
University of Michigan–Ann Arbor · US

Funding

XenograftP30CA046592 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Alexey I Nesvizhskii · 1988 to 2026
$178.2M
Linking epigenetic regulation and TGF-β signaling in pancreatic cancerK08CA234222 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SHI, JIAQI · 2018 to 2021
$744k
Role of Interleukin-22 and Innate Lymphoid Cells in Pancreas Cancer Initiation and ProgressionK08CA201581 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI FRANKEL, TIMOTHY LOUIS · 2016 to 2020
$703k
NCI NIH HHS K08 CA201581NCI NIH HHS K08 CA234222NCI NIH HHS P30 CA046592
6 · The paper itself

Abstract

Microenvironment evaluation of intact tissue for analysis of cell infiltration and spatial organization are essential in understanding the complexity of disease processes. The principle techniques used in the past include immunohistochemistry (IHC) and immunofluorescence (IF) which enable visualization of cells as a snapshot in time using between 1 and 4 markers. Both techniques have shortcomings including difficulty staining poorly antigenic targets and limitations related to cross-species reactivity. IHC is reliable and reproducible, but the nature of the chemistry and reliance on the visible light spectrum allows for only a few markers to be used and makes co-localization challenging. Use of IF broadens potential markers but typically relies on frozen tissue due to the extensive tissue autofluorescence following formalin fixation. Flow cytometry, a technique that enables simultaneous labeling of multiple epitopes, abrogates many of the deficiencies of IF and IHC, however, the need to examine cells as a single cell suspension loses the spatial context of cells discarding important biologic relationships. Multiplex fluorescent immunohistochemistry (mfIHC) bridges these technologies allowing for multi-epitope cellular phenotyping in formalin fixed paraffin embedded (FFPE) tissue while preserving the overall microenvironment architecture and spatial relationship of cells within intact undisrupted tissue. High fluorescent intensity fluorophores that covalently bond to the tissue epitope enables multiple applications of primary antibodies without worry of species specific cross-reactivity by secondary antibodies. Although this technology has been proven to produce reliable and accurate images for the study of disease, the process of creating a useful mfIHC staining strategy can be time consuming and exacting due to extensive optimization and design. In order to make robust images that represent accurate cellular interactions in-situ and to mitigate the optimization period for manual analysis, presented here are methods for slide preparation, optimizing antibodies, multiplex design as well as errors commonly encountered during the staining process.

Indexed as

AntibodiesColonic NeoplasmsFluorescent Antibody TechniqueFormaldehydeHumansImmunohistochemistryParaffin EmbeddingStaining and LabelingAntibodiesFormaldehyde

Identifiers

PMID31403624
PMCPMC6786767
OpenAlexW2966021190

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.